0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 41-60 of 572 Articles
JAMA Oncology | 
Research Letter |  ONLINE FIRST
Nabil Adra, MD; Hamid Sayar, MD; Lawrence H. Einhorn, MD
JAMA Oncol. Published online December 03, 2015. doi:10.1001/jamaoncol.2015.4837

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Shelli R. Kesler, PhD; Douglas W. Blayney, MD
JAMA Oncol. Published online December 03, 2015. doi:10.1001/jamaoncol.2015.4333
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Douglas B. Johnson, MD; Ryan J. Sullivan, MD; Patrick A. Ott, MD, PhD; et al.
JAMA Oncol. Published online December 03, 2015. doi:10.1001/jamaoncol.2015.4368
Includes: Supplemental Content

JAMA Neurology | 
Research Letter | 
Karen Joan Suetterlin, MRCP; Enrico Bugiardini, MD; Juan P. Kaski, MRCPCH, MD(Res); et al.
JAMA Neurol. 2015;72(12):1531-1533. doi:10.1001/jamaneurol.2015.2338.

JAMA Psychiatry | 
Editorial | 
Guy M. Goodwin, FMedSci
JAMA Psychiatry. 2015;72(12):1167-1169. doi:10.1001/jamapsychiatry.2015.2014.

JAMA Psychiatry | 
Original Investigation | 
Lars Vedel Kessing, MD, DMSc; Thomas Alexander Gerds, PhD; Bo Feldt-Rasmussen, MD, DMSc; et al.
JAMA Psychiatry. 2015;72(12):1182-1191. doi:10.1001/jamapsychiatry.2015.1834.
Includes: Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Enrico Mossello, MD, PhD
JAMA Intern Med. 2015;175(12):1949-1950. doi:10.1001/jamainternmed.2015.5941.

JAMA Internal Medicine | 
Research Letter | 
Tanner J. Caverly, MD, MPH; Angela Fagerlin, PhD; Brian J Zikmund-Fisher, PhD; et al.
JAMA Intern Med. 2015;175(12):1994-1996. doi:10.1001/jamainternmed.2015.5950.

JAMA Internal Medicine | 
Original Investigation | 
Jeremy B. Sussman, MD, MS; Eve A. Kerr, MD, MPH; Sameer D. Saini, MD, MS; et al.
JAMA Intern Med. 2015;175(12):1942-1949. doi:10.1001/jamainternmed.2015.5110.
Includes: Supplemental Content

JAMA Ophthalmology | 
Original Investigation | 
Penny A. Asbell, MD, MBA; Christine M. Sanfilippo, PhD; Christopher M. Pillar, PhD; et al.
JAMA Ophthalmol. 2015;133(12):1445-1454. doi:10.1001/jamaophthalmol.2015.3888.
Includes: CME

JAMA Neurology | 
Editorial | 
Tiffany Cossey, MD; Nicole R. Gonzales, MD
JAMA Neurol. 2015;72(12):1416-1418. doi:10.1001/jamaneurol.2015.2900.

JAMA Neurology | 
Original Investigation | 
Shadi Yaghi, MD; Amelia K. Boehme, MSPH, PhD; Jamil Dibu, MD; et al.
JAMA Neurol. 2015;72(12):1451-1457. doi:10.1001/jamaneurol.2015.2371.
Includes: CME, Supplemental Content

JAMA Internal Medicine | 
Research Letter | 
Nynne Nyboe Andersen, MD; Björn Pasternak, MD, PhD; Mikael Andersson, MSc; et al.
JAMA Intern Med. 2015;175(12):1990-1992. doi:10.1001/jamainternmed.2015.5396.

JAMA Internal Medicine | 
Original Investigation | 
Mads E. Jørgensen, MB; Mark A. Hlatky, MD; Lars Køber, MD, DSc; et al.
JAMA Intern Med. 2015;175(12):. doi:10.1001/jamainternmed.2015.5346.
Includes: Supplemental Content

JAMA Neurology | 
Editorial | 
Dennis Bourdette, MD; Daniel Hartung, PharmD, MPH
JAMA Neurol. 2015;72(12):1411-1413. doi:10.1001/jamaneurol.2015.2605.

JAMA Neurology | 
Original Investigation | 
Jeffrey Cohen, MD; Anna Belova, MD; Krzysztof Selmaj, MD; et al.
JAMA Neurol. 2015;72(12):1433-1441. doi:10.1001/jamaneurol.2015.2154.
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary | 
Rashmi Chugh, MD; Scott M. Schuetze, MD, PhD
JAMA Oncol. 2015;1(9):1280-1281. doi:10.1001/jamaoncol.2015.3221.

JAMA Oncology | 
Original Investigation | 
Sindy Magnan, MD, MSc, FRCPC; Ryan Zarychanski, MD, MSc, FRCPC; Laurie Pilote, MD; et al.
JAMA Oncol. 2015;1(9):1261-1269. doi:10.1001/jamaoncol.2015.2895.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  Open Access
Sant P. Chawla, MD; Zsuzsanna Papai, MD; Guzel Mukhametshina, MD; et al.
JAMA Oncol. 2015;1(9):1272-1280. doi:10.1001/jamaoncol.2015.3101.
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Rebecca M. Prince, MBBS, FRACP; Eshetu G. Atenafu, MSc, PStat; Monika K. Krzyzanowska, MD, MPH, FRCPC
JAMA Oncol. 2015;1(9):1333-1339. doi:10.1001/jamaoncol.2015.3440.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA
From The Medical Letter on Drugs and Therapeutics  | 
Drugs Past Their Expiration Date

JAMA Internal Medicine
Editorial  | 
Vitamin D Supplementation and Increased Risk of Falling A Cautionary Tale of Vitamin Supplements Retold
Steven R. Cummings, MD; Douglas P. Kiel, MD, MPH; Dennis M. Black, PhD